20/20 BIOLABS, INC.: rnd_expense
| Value | {"amount": 153482, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} |
|---|---|
| Period | 2026-01-01 – 2026-03-31 |
| Status | current |
| Entity | 20/20 BIOLABS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/69461c8b-9fda-49c1-9eb2-286cb373835b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-059542 · Open the official SEC filing →Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001139685/rnd-expense/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/69461c8b-9fda-49c1-9eb2-286cb373835b
History
- no predecessors — first report